首页>
外国专利>
Dihidropiridona P1 as factor XIa inhibitors
Dihidropiridona P1 as factor XIa inhibitors
展开▼
机译:DI Hi drop i日Don AP1 as factor X IA inhibitors
展开▼
页面导航
摘要
著录项
相似文献
摘要
Pharmaceutical ingredients including these compounds and methods of treating hemoglobin and / or inflammation. 1. Characteristic requirement 1: a compound, whose characteristic is formula (1) or stereoisomer, a ceramic strength meter or a salt, and its medicament is acceptable, wherein: Ring A is independent of a set of formula (2);- - - - is an optional link; R¹ is independently selected from H, hydroxy and C₁₋₄ alkyl;R2,in each case, it is independently selected from H and hydroxyl; R⁴ is independently selected from H, OH, F, O-C₁₋₄ alkyl and CN; R⁸ᵃ is independently selected from H, F, Cl and Br; R⁸ᵇ is independently selected from H and F; and R⁸ᶜ is independently selected from H, F and CI.
展开▼
机译:包括这些化合物的药物成分以及治疗血红蛋白和/或炎症的方法。 1.特性要求1:可接受的是特征在于式(1)或立体异构体的化合物,陶瓷强度计或盐及其药物,其中:A环独立于一组式(2);- -是可选链接; R 1独立地选自H,羟基和C 1-4烷基; R 2在每种情况下均独立地选自H和羟基; R 5独立地选自H,OH,F,O-C 1烷基和CN; R 3独立地选自H,F,Cl和Br; R⁸ᵇ独立地选自H和F; R⁸ᶜ独立地选自H,F和CI。
展开▼